485 related articles for article (PubMed ID: 30846085)
1. The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study.
Wood DA; Lauck SB; Cairns JA; Humphries KH; Cook R; Welsh R; Leipsic J; Genereux P; Moss R; Jue J; Blanke P; Cheung A; Ye J; Dvir D; Umedaly H; Klein R; Rondi K; Poulter R; Stub D; Barbanti M; Fahmy P; Htun N; Murdoch D; Prakash R; Barker M; Nickel K; Thakkar J; Sathananthan J; Tyrell B; Al-Qoofi F; Velianou JL; Natarajan MK; Wijeysundera HC; Radhakrishnan S; Horlick E; Osten M; Buller C; Peterson M; Asgar A; Palisaitis D; Masson JB; Kodali S; Nazif T; Thourani V; Babaliaros VC; Cohen DJ; Park JE; Leon MB; Webb JG
JACC Cardiovasc Interv; 2019 Mar; 12(5):459-469. PubMed ID: 30846085
[TBL] [Abstract][Full Text] [Related]
2. Transcarotid Approach for Transcatheter Aortic Valve Replacement With the Sapien 3 Prosthesis: A Multicenter French Registry.
Overtchouk P; Folliguet T; Pinaud F; Fouquet O; Pernot M; Bonnet G; Hubert M; Lapeze J; Claudel JP; Ghostine S; Azmoun A; Caussin C; Zannis K; Harmouche M; Verhoye JP; Lafont A; Chamandi C; Ruggieri VG; Di Cesare A; Leclercq F; Gandet T; Modine T
JACC Cardiovasc Interv; 2019 Mar; 12(5):413-419. PubMed ID: 30772290
[TBL] [Abstract][Full Text] [Related]
3. Safety and predictors of next-day discharge after elective transfemoral transcatheter aortic valve replacement.
Rathore S; Latyshev Y; Emore S; Rowe J; Foerst J
Cardiovasc Revasc Med; 2017 Dec; 18(8):583-587. PubMed ID: 28551423
[TBL] [Abstract][Full Text] [Related]
4. Safety of Next-Day Discharge After Transfemoral Transcatheter Aortic Valve Replacement With a Self-Expandable Versus Balloon-Expandable Valve Prosthesis.
Moriyama N; Vento A; Laine M
Circ Cardiovasc Interv; 2019 Jun; 12(6):e007756. PubMed ID: 31167602
[TBL] [Abstract][Full Text] [Related]
5. Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway: Minimalist Approach, Standardized Care, and Discharge Criteria to Reduce Length of Stay.
Lauck SB; Wood DA; Baumbusch J; Kwon JY; Stub D; Achtem L; Blanke P; Boone RH; Cheung A; Dvir D; Gibson JA; Lee B; Leipsic J; Moss R; Perlman G; Polderman J; Ramanathan K; Ye J; Webb JG
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):312-21. PubMed ID: 27116975
[TBL] [Abstract][Full Text] [Related]
6. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
[TBL] [Abstract][Full Text] [Related]
7. Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
Drafts BC; Choi CH; Sangal K; Cammarata MW; Applegate RJ; Gandhi SK; Kincaid EH; Kon N; Zhao DX
Catheter Cardiovasc Interv; 2018 Jun; 91(7):1354-1362. PubMed ID: 29024382
[TBL] [Abstract][Full Text] [Related]
8. Length of Stay After Transfemoral Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
Wayangankar SA; Elgendy IY; Xiang Q; Jneid H; Vemulapalli S; Khachatryan T; Pham D; Hilliard AA; Kapadia SR
JACC Cardiovasc Interv; 2019 Mar; 12(5):422-430. PubMed ID: 30846079
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.
Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of transcatheter aortic valve replacement using a minimalist approach.
Gurevich S; Oestreich B; Kelly RF; Mbai M; Bertog S; Ringsred K; Lawton A; Thooft B; Wagner J; Garcia S
Cardiovasc Revasc Med; 2018 Mar; 19(2):192-195. PubMed ID: 28923694
[TBL] [Abstract][Full Text] [Related]
11. Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist Transfemoral Transcatheter Aortic Valve Replacement.
Kamioka N; Wells J; Keegan P; Lerakis S; Binongo J; Corrigan F; Condado J; Patel A; Forcillo J; Ogburn L; Dong A; Caughron H; Simone A; Leshnower B; Devireddy C; Mavromatis K; Guyton R; Stewart J; Thourani V; Block PC; Babaliaros V
JACC Cardiovasc Interv; 2018 Jan; 11(2):107-115. PubMed ID: 29348004
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.
Pagnesi M; Kim WK; Conradi L; Barbanti M; Stefanini GG; Zeus T; Pilgrim T; Schofer J; Zweiker D; Testa L; Taramasso M; Hildick-Smith D; Abizaid A; Wolf A; Van Mieghem NM; Sedaghat A; Wöhrle J; Khogali S; Van der Heyden JAS; Webb JG; Estévez-Loureiro R; Mylotte D; MacCarthy P; Brugaletta S; Hamm CW; Bhadra OD; Schäfer U; Costa G; Tamburino C; Cannata F; Reimers B; Veulemans V; Asami M; Windecker S; Eitan A; Schmidt A; Bianchi G; Bedogni F; Saccocci M; Maisano F; Alsanjari O; Siqueira D; Jensen CJ; Naber CK; Ziviello F; Sinning JM; Seeger J; Rottbauer W; Brouwer J; Alenezi A; Wood DA; Tzalamouras V; Regueiro A; Colombo A; Latib A
JACC Cardiovasc Interv; 2019 Mar; 12(5):433-443. PubMed ID: 30846081
[TBL] [Abstract][Full Text] [Related]
13. Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement.
Guo R; Xie M; Yim WY; Wu W; Jiang W; Wang Y; Hu X
BMC Cardiovasc Disord; 2021 Jul; 21(1):358. PubMed ID: 34320946
[TBL] [Abstract][Full Text] [Related]
14. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
[TBL] [Abstract][Full Text] [Related]
15. Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration.
Vlastra W; Chandrasekhar J; Vendrik J; Gutierrez-Ibanes E; Tchétché D; de Brito FS; Barbanti M; Kornowski R; Latib A; D'Onofrio A; Ribichini F; Baan J; Tijssen JGP; Pan M; Dumonteil N; Mangione JA; Sartori S; D'Errigo P; Tarantini G; Lunardi M; Orvin K; Pagnesi M; Sanchez Gila J; Modine T; Dangas G; Mehran R; Piek JJ; Delewi R
JACC Cardiovasc Interv; 2019 May; 12(10):911-920. PubMed ID: 31122347
[TBL] [Abstract][Full Text] [Related]
16. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning.
Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R
Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313
[TBL] [Abstract][Full Text] [Related]
17. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
[TBL] [Abstract][Full Text] [Related]
18. Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry.
Sorajja P; Kodali S; Reardon MJ; Szeto WY; Chetcuti SJ; Hermiller J; Chenoweth S; Adams DH; Popma JJ
JACC Cardiovasc Interv; 2017 Oct; 10(20):2090-2098. PubMed ID: 29050627
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.
Mack MJ; Leon MB; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Pibarot P; Leipsic J; Hahn RT; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Genereux P; Pershad A; Pocock SJ; Alu MC; Webb JG; Smith CR;
N Engl J Med; 2019 May; 380(18):1695-1705. PubMed ID: 30883058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
